For decades, venture capitalists have relied on a tried-and-true recipe to make money in biotech. Now that approach is being ...

Microsoft has backed out of building data centers, Intel's factory opening has been delayed to 2030, but one tech industry is going strong in central Ohio: Biotechnology. The now multibillion dollar ...

Over the past couple of years, the integration of Artificial Intelligence (AI) has ignited a revolutionary shift within the biotechnology industry. By mining massive biological datasets, AI has been ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

T he biotech and pharmaceutical sectors stand at the brink of innovation and strategic transformation. Market momentum continues to build, with the global biotechnology market valued at around $2 ...

Fierce Biotech sat down with Pavel Raifeld, CEO of Innoviva, to explore the dynamic landscape of the biotech industry. Throughout the conversation, Raifeld offers a unique perspective on the most ...

CHICAGO--(BUSINESS WIRE)--The global pandemic is accelerating once lofty ideals of collaboration and innovation in the biotech industry. According to a new analysis from professional services firm BDO ...

For years, public debate around U.S. dependence on China has focused on semiconductors, consumer electronics, rare earth minerals and industrial manufacturing. Far less attention has been paid to a ...

Biotech has a big footprint in Massachusetts, and according to a 2023 report, women make up less than 6% of leadership roles in the industry. We asked some women who are in those positions on how ...